Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Greiner

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Scientific Reports|February 8, 2017
Chloroquine inhibits human CD4<sup>+</sup> T-cell activation by AP-1 signaling modulationRalf L J Schmidt, Sabrina Jutz, Katrin Goldhahn, et al.
Virulence|July 30, 2020
Development of a fully automated high throughput PCR for the detection of SARS-CoV-2: The need for speedFlorian J Mayer, Franz Ratzinger, Ralf L J Schmidt, et al.
British Journal of Haematology|July 15, 2017
Expansion of BCR/ABL1<sup>+</sup> cells requires PAK2 but not PAK1Leo Edlinger, Angelika Berger-Becvar, Ingeborg Menzl, et al.
Blood|November 19, 2016
CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosisGeorg Greiner, Nadine Witzeneder, Angelika Berger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 25, 2014
CD52 is a molecular target in advanced systemic mastocytosisGregor Hoermann, Katharina Blatt, Georg Greiner, et al.
American Journal of Hematology|January 2, 2023
N-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemiaIrene Graf, Georg Greiner, Rodrig Marculescu, et al.
American Journal of Cancer Research|April 1, 2021
Impact of <i>HFE</i> gene variants on iron overload, overall survival and leukemia-free survival in myelodysplastic syndromesMathias Schneeweiss-Gleixner, Georg Greiner, Susanne Herndlhofer, et al.
Neoplasia (New York, N.Y.)|November 3, 2021
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosisDaniela Berger, Karin Bauer, Christoph Kornauth, et al.
Haematologica|June 10, 2017
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemiaKaroline V Gleixner, Mathias Schneeweiss, Gregor Eisenwort, et al.
Ebiomedicine|November 26, 2019
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1<sup>T315I</sup>+ clones in TKI-resistant CMLMathias Schneeweiss-Gleixner, Konstantin Byrgazov, Gabriele Stefanzl, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Scientific Reports|February 8, 2017
Chloroquine inhibits human CD4<sup>+</sup> T-cell activation by AP-1 signaling modulationRalf L J Schmidt, Sabrina Jutz, Katrin Goldhahn, et al.
Virulence|July 30, 2020
Development of a fully automated high throughput PCR for the detection of SARS-CoV-2: The need for speedFlorian J Mayer, Franz Ratzinger, Ralf L J Schmidt, et al.
British Journal of Haematology|July 15, 2017
Expansion of BCR/ABL1<sup>+</sup> cells requires PAK2 but not PAK1Leo Edlinger, Angelika Berger-Becvar, Ingeborg Menzl, et al.
Blood|November 19, 2016
CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosisGeorg Greiner, Nadine Witzeneder, Angelika Berger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 25, 2014
CD52 is a molecular target in advanced systemic mastocytosisGregor Hoermann, Katharina Blatt, Georg Greiner, et al.
American Journal of Hematology|January 2, 2023
N-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemiaIrene Graf, Georg Greiner, Rodrig Marculescu, et al.
American Journal of Cancer Research|April 1, 2021
Impact of <i>HFE</i> gene variants on iron overload, overall survival and leukemia-free survival in myelodysplastic syndromesMathias Schneeweiss-Gleixner, Georg Greiner, Susanne Herndlhofer, et al.
Neoplasia (New York, N.Y.)|November 3, 2021
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosisDaniela Berger, Karin Bauer, Christoph Kornauth, et al.
Haematologica|June 10, 2017
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemiaKaroline V Gleixner, Mathias Schneeweiss, Gregor Eisenwort, et al.
Ebiomedicine|November 26, 2019
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1<sup>T315I</sup>+ clones in TKI-resistant CMLMathias Schneeweiss-Gleixner, Konstantin Byrgazov, Gabriele Stefanzl, et al.
Pageof 6